Cargando…

The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor

Mouse hepatitis virus A59 (MHV-A59) is a representative member of the genus betacoronavirus within the subfamily Coronavirinae, which infects the liver, brain and respiratory tract. Through different inoculation routes, MHV-A59 can provide animal models for encephalitis, hepatitis and pneumonia to e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Wen, Cui, Shanshan, Chen, Cheng, Chen, Xia, Wang, Zefang, Yang, Haitao, Zhang, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185540/ https://www.ncbi.nlm.nih.gov/pubmed/30833083 http://dx.doi.org/10.1016/j.bbrc.2019.02.105

Ejemplares similares

Corrigendum to “The crystal structure of main protease from mouse hepatitis virus A59 in complex with an inhibitor” [BBRC 511/4 (2019) 794–799]
por: Cui, Wen, et al.
Publicado: (2019)

Crystallization and preliminary crystallographic study of Porcine epidemic diarrhea virus main protease in complex with an inhibitor
por: Tan, Yusheng, et al.
Publicado: (2014)

Crystallization and preliminary crystallographic study of Feline infectious peritonitis virus main protease in complex with an inhibitor
por: Wang, Jinshan, et al.
Publicado: (2014)

Crystal Structure of Human Coronavirus NL63 Main Protease in Complex With an Inhibitor
por: Yang, Kailin, et al.
Publicado: (2015)

Crystallization and preliminary crystallographic study of human coronavirus NL63 main protease in complex with an inhibitor
por: Wang, Fenghua, et al.
Publicado: (2014)

Crystal structure of SARS-CoV-2 main protease in complex with protease inhibitor PF-07321332
por: Zhao, Yao, et al.
Publicado: (2021)

The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals
por: Wang, Fenghua, et al.
Publicado: (2022)

SAR and QSAR of COVID-19 Main Protease–Inhibitor Interactions of Recently X-ray Crystalized Complexes
por: Ali, Hussein M., et al.
Publicado: (2022)

Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188
por: Lockbaum, Gordon J., et al.
Publicado: (2021)

Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses
por: Zvornicanin, Sarah N., et al.
Publicado: (2023)

Crystal Structure of the C-Terminal Cytoplasmic Domain of Non-Structural Protein 4 from Mouse Hepatitis Virus A59
por: Xu, Xiaoling, et al.
Publicado: (2009)

Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

The peptide specificities of the autoantibodies elicited by mouse hepatitis virus A59
por: Duhalde-Vega, Maite, et al.
Publicado: (2006)

Correction: Design of Wide-Spectrum Inhibitors Targeting Coronavirus Main Proteases
por: Yang, Haitao, et al.
Publicado: (2005)

Systematic Assembly and Genetic Manipulation of the Mouse Hepatitis Virus A59 Genome
por: Donaldson, Eric F., et al.
Publicado: (2007)

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
por: Cui, Wen, et al.
Publicado: (2020)

Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
por: Wang, Li, et al.
Publicado: (2017)

Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode
por: Li, Jian, et al.
Publicado: (2021)

Protease inhibitors for the treatment of hepatitis C virus infection
por: de Leuw, Philipp, et al.
Publicado: (2017)

PLP2 of Mouse Hepatitis Virus A59 (MHV-A59) Targets TBK1 to Negatively Regulate Cellular Type I Interferon Signaling Pathway
por: Wang, Gang, et al.
Publicado: (2011)

Allosteric inhibitors of the main protease of SARS-CoV-2
por: Samrat, Subodh Kumar, et al.
Publicado: (2022)

In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus
por: Eleftheriou, Phaedra, et al.
Publicado: (2020)

Individual and common inhibitors of coronavirus and picornavirus main proteases
por: Kuo, Chih-Jung, et al.
Publicado: (2009)

The Therapeutic Approaches for Hepatitis C Virus: Protease Inhibitors and Polymerase Inhibitors
por: Kwo, Paul Y., et al.
Publicado: (2011)

The autoimmune response induced by mouse hepatitis virus A59 is expanded by a hepatotoxic agent
por: Aparicio, José L., et al.
Publicado: (2009)

Isolation and identification of virus-specific mRNAs in cells infected with mouse hepatitis virus (MHV-A59)
por: Spaan, Willy J.M., et al.
Publicado: (1981)

Crystal structures of inhibitor complexes of M‐PMV protease with visible flap loops
por: Wosicki, Stanislaw, et al.
Publicado: (2021)

The crystal structure of Zika virus helicase: basis for antiviral drug design
por: Tian, Hongliang, et al.
Publicado: (2016)

Autoimmune hepatitis-like disease in C57BL/6 mice infected with mouse hepatitis virus A59
por: Aparicio, José L., et al.
Publicado: (2011)

Site of addition of N-acetyl-galactosamine to the E1 glycoprotein of mouse hepatitis virus-A59
Publicado: (1988)

Mouse hepatitis virus A59-induced demyelination can occur in the absence of CD8(+) T cells
por: Gombold, James L., et al.
Publicado: (1995)

Temperature-sensitive mutants of mouse hepatitis virus strain A59: Isolation, characterization and neuropathogenic properties
por: Koolen, Marck J.M., et al.
Publicado: (1983)

Sequence similarity and structural homologies are involved in the autoimmune response elicited by mouse hepatitis virus A59
por: Mathieu, Patricia A., et al.
Publicado: (2004)

Replication of Synthetic Defective Interfering RNAs Derived from Coronavirus Mouse Hepatitis Virus-A59
por: LUYTJES, WILLEM, et al.
Publicado: (1996)

C1qa deficiency in mice increases susceptibility to mouse hepatitis virus A59 infection
por: Kim, Han-Woong, et al.
Publicado: (2021)

Potential SARS-CoV-2 main protease inhibitors
por: Banerjee, Riddhidev, et al.
Publicado: (2021)

Developing inhibitors of the SARS-CoV-2 main protease
por: Seitz, Christian, et al.
Publicado: (2022)

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
por: Liu, Jian, et al.
Publicado: (2021)

Analysis of the efficacy of HIV protease inhibitors against SARS-CoV-2′s main protease
por: Mahdi, Mohamed, et al.
Publicado: (2020)

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
por: Zhang, Linlin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m18qud0fssm1bulq1kdgdtj8ff